What type of study is this?

October 2, 2025Cancer ReportsOpen Access

Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single‐Center Retrospective Analysis

View Full Paper

Ask AI

Bookmark

Authors

MFMarta Garcia FasanellaHospital de Sant Pau AMAnna MozosHospital de Sant Pau JBJavier BrionesHospital de Sant Pau

Discussion

Member takes

Implication

Retrospective analysis reveals treatment response and complications in hairy cell leukemia patients, suggesting targeted therapies may reduce adverse effects.

Key Points

Cladribine treatment achieved a complete response in 77.8% of hairy cell leukemia patients.
Infections impacted 38% of patients, highlighting significant treatment complications.
The study analyzed outcomes from 21 patients treated between 2009 and 2023.
Introduction of BRAF inhibitors shows promise for patients intolerant to traditional treatments.

Cite This Study

Fasanella et al. (2025) studied this question.

synapsesocial.com/papers/68de68e583cbc991d0a2107f https://doi.org/10.1002/cnr2.70356

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis reveals treatment response and complications in hairy cell leukemia patients, suggesting targeted therapies may reduce adverse effects.

Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single‐Center Retrospective Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluation of Clinical Outcomes and Treatment Complications in Hairy Cell Leukemia: A Single‐Center Retrospective Analysis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider